Orgametril (Lynestrenol)

Orgametril, containing the progestogen lynestrenol, is used within hormonal contraceptive regimens to prevent pregnancy.

• Contraception: prevents ovulation and implantation, providing reliable birth control.
• Menstrual cycle regulation: helps achieve more predictable menstrual bleeding when used in combination therapy.
• Endometrial protection: induces changes in the uterine lining that reduce the risk of breakthrough bleeding.

• Lynestrenol binds to progesterone receptors in the hypothalamus and pituitary, suppressing the luteinizing hormone surge and thereby inhibiting ovulation. It also induces endometrial transformation that makes the uterine environment unsuitable for implantation, contributing to its contraceptive effect.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Headache: transient tension‑type headaches.
• Breast tenderness: mild discomfort or swelling.
• Weight gain: modest increase in body weight.
• Mood changes: occasional irritability or mood swings.
• Spotting: irregular light bleeding.

Serious or Rare Side Effects

• Venous thromboembolism: deep vein thrombosis or pulmonary embolism.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Liver dysfunction: jaundice or elevated liver enzymes.

Before initiating therapy, consider the following precautions:

• Thrombotic risk assessment: evaluate personal or family history of clotting disorders.
• Liver function review: avoid use in patients with active liver disease.
• Smoking status: counsel smokers, especially over age 35, about increased cardiovascular risk.
• Medication review: check for drugs that may reduce contraceptive efficacy.
• Pregnancy avoidance: do not use during pregnancy; use alternative contraception if pregnancy is confirmed.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Lynestrenol may interact with several medications, requiring careful management.

Major Interactions (Avoid)

• Enzyme inducers (e.g., rifampicin): may markedly reduce contraceptive effectiveness.
• Strong antifungals (e.g., ketoconazole): can increase hormone levels, raising side‑effect risk.
• Protease inhibitors (e.g., ritonavir): may alter metabolism and efficacy.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (e.g., phenytoin): may lower plasma concentrations.
• St. John’s wort: may decrease contraceptive reliability.
• Certain antibiotics (e.g., erythromycin): may modestly affect hormone levels.